Initially investigated for its potential effects on digestive tissue, researchers soon noticed possible activity in other areas of healing biology, including: Connective tissue repair Tendon and ligament healing Muscle recovery Blood vessel formation Inflammatory signaling Gastrointestinal integrity Rather than acting through a single mechanism, researchers believe BPC-157 may interact with multiple pathways involved in tissue repair and regeneration
There are currently no human RCTs demonstrating that systemic or intranasal administration of GHK-Cu reverses age-related cognitive decline, Alzheimers, or neurodegeneration in human subjects
Rare but potentially serious adverse effects require careful consideration and monitoring
Well just see more of that if the FDA decides to turn a blind eye to compounding and marketing of these peptides
Theoretically, combining it with cagrilintide could provide triple-mechanism coverage: amylin receptor activation (cagrilintide) plus GIP and GLP-1 receptor activation (tirzepatide)
Whether or not that framing fully resolves the regulatory picture, it is the lens he uses for everything that follows
